Does discontinuing or not adhering to aspirin worsen prognosis in patients at risk for coronary artery disease?
Discontinuing aspirin in patients at moderate-to-high risk for CAD is associated with adverse prognostic implications and should only be done when bleeding risk clearly outweighs atherothrombotic risk.
Non-compliance or withdrawal of aspirin treatment has ominous prognostic implication in subjects with or at moderate-to-high risk for CAD. Aspirin discontinuation in such patients should be advocated only when bleeding risk clearly overwhelms that of atherothrombotic events.
Biondi‐Zoccai et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: